Abstract:Synthetic biology holds promise to revolutionize the life sciences and biomedicine via expansion of macromolecular diversity outside the natural chemical space. Use of non-canonical amino acids (ncAAs) via codon reassignment has found diverse applications in protein structure and interaction analysis, introduction of post-translational modifications, production of constrained peptides, antibody-drug conjugates, and novel enzymes. However, simultaneously encoding multiple ncAAs in vivo requires complex engineering and is sometimes restricted by the cell's poor uptake of ncAAs. In contrast the open nature of cell-free protein synthesis systems offers much greater freedom for manipulation and repurposing of the biosynthetic machinery by controlling the level and identity of translational components and reagents, and allows simultaneous incorporation of multiple ncAAs with non-canonical side chains and even backbones (N-methyl, D-, β-amino acids, α-hydroxy acids etc.). This review focuses on the two most used Escherichia coli-based cell-free protein synthesis systems; cell extract- and PURE-based systems. The former is a biological mixture with >500 proteins, while the latter consists of 38 individually purified biomolecules. We delineate compositions of these two systems and discuss their respective advantages and applications. Also, we dissect the translational components required for ncAA incorporation and compile lists of ncAAs that can be incorporated into polypeptides via different acylation approaches. We highlight the recent progress in using unnatural nucleobase pairs to increase the repertoire of orthogonal codons, as well as using tRNA-specific ribozymes for in situ acylation. We summarize advances in engineering of translational machinery such as tRNAs, aminoacyl-tRNA synthetases, elongation factors, and ribosomes to achieve efficient incorporation of structurally challenging ncAAs. We note that, many engineered components of biosynthetic machinery are developed for the use in vivo but are equally applicable to the in vitro systems. These are included in the review to provide a comprehensive overview for ncAA incorporation and offer new insights for the future development in cell-free systems. Finally, we highlight the exciting progress in the genomic engineering, resulting in E. coli strains free of amber and some redundant sense codons. These strains can be used for preparation of cell extracts offering multiple reassignment options.

Cheminformatics-Guided Cell-Free Exploration of Peptide Natural Products

Cell-free Protein Synthesis Enabled Rapid Prototyping for Metabolic Engineering and Synthetic Biology

Synthetic-bioinformatic natural product-inspired peptides

Cell-free synthetic biology for in vitro biosynthesis of pharmaceutical natural products

Exploring the Potential of Cell-Free Protein Synthesis for Extending the Abilities of Biological Systems

Cell-Free Approach for Non-canonical Amino Acids Incorporation Into Polypeptides

Chemical Strategies for Visualizing and Analyzing Endogenous Nonribosomal Peptide Synthetase (NRPS) Megasynthetases

Computational peptide discovery with a genetic programming approach

Cell-Free Synthesis of Natural Compounds from Genomic DNA of Biosynthetic Gene Clusters

Computational Tools for Discovering and Engineering Natural Product Biosynthetic Pathways

Next-generation synthetic biology approaches for the accelerated discovery of microbial natural products

Cell-free protein synthesis with technical additives - expanding the parameter space of in vitro gene expression

A mass spectrometry–guided genome mining approach for natural product peptidogenomics

Virtual Screening Expands the Non-Natural Amino Acid Palette for Peptide Optimization

Genetically programmed cell-based synthesis of non-natural peptide and depsipeptide macrocycles

Pseudo Natural Products—Chemical Evolution of Natural Product Structure

Advances in cell-free protein synthesis

A Cell‐Free Platform Based on Nisin Biosynthesis for Discovering Novel Lanthipeptides and Guiding their Overproduction In Vivo

High-Throughput Peptide Derivatization toward Supramolecular Diversification in Microtiter Plates

Bioinformatic approaches to the identification of novel neuropeptide precursors

Deep generative models for peptide design